HLA-C and cancer: Furthermore, their MHC-unrestricted recognition of malignant cells reduces the likelihood of graft-versus-host disease (GVHD)599 and enables them to overcome immune evasion strategies employed by cancers, such as downregulated MHC molecule expression.